Chronic Kidney Disease Market: 10-Year Growth Projections and Regional Insights
25. November 2024 07:13 ET
|
Research and Markets
Dublin, Nov. 25, 2024 (GLOBE NEWSWIRE) -- The "Chronic Kidney Disease: 68-Market Analysis and Sales Forecast" report has been added to ResearchAndMarkets.com's offering.This report covers the 68...
Critical Gaps in FSGS Treatment Highlight Need for New Therapies, with Pipeline Assets from Travere, Vertex, and Dimerix Poised to Address Unmet Needs
01. November 2024 09:17 ET
|
Spherix Global Insights
EXTON, PA, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Focal segmental glomerulosclerosis (FSGS), one of the most common glomerular diseases seen by nephrologists, ranks among the top three rare kidney...
Simple HealthKit Launches Expanded Kidney Health Evaluation for Patients with Diabetes (KED) Program to Help Payers Improve Patient Health, Boost STAR Ratings & Meet HEDIS Measures
26. Februar 2024 09:00 ET
|
Simple HealthKit
Simple HealthKit has launched a new Kidney Health Evaluation for Patients with Diabetes (KED) program to help healthcare payers improve patient health.
Global Chronic Kidney Disease Market Poised for Growth, Projected to Reach $83.6 Billion by 2030
23. Januar 2024 03:08 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Chronic Kidney Disease Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. ...
Use of SGLT2 Inhibitors Continues to Expand for the Treatment of Chronic Kidney Disease, with Eli Lilly/Boehringer Ingelheim’s Jardiance Making Significant Strides Following Label Expansion
03. Januar 2024 16:13 ET
|
Spherix Global Insights
EXTON, PA, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Since 2019, audited records of chronic kidney disease (CKD) non-dialysis patients has revealed an ongoing, annual uptick in the proportion of...
Organ Preservation Solution Market worth $399.49 Billion by 2028 - Exclusive Report by The Insight Partners
08. September 2023 06:48 ET
|
The Insight Partners
Pune, India, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Organ preservation solutions are used to protect organs prior to transplantation because organs in the outer environment often collapse once removed...
Akebia’s Vafseo (vadadustat) Poised to Make Waves for GSK’s Jesduvroq and FibroGen/Astellas’ Evrenzo
20. Juli 2023 15:07 ET
|
Spherix Global Insights
Exton, Pennsylvania, July 20, 2023 (GLOBE NEWSWIRE) -- Nephrologists have long awaited the approval of HIF-PH inhibitors for the treatment of anemia in their chronic kidney disease (CKD) patients....
Hemodialysis Market Size is projected to reach USD 136.84 Billion by 2031, growing at a CAGR of 4.8%: Straits Research
06. Dezember 2022 10:15 ET
|
Straits Research
New York, United States, Dec. 06, 2022 (GLOBE NEWSWIRE) -- A hemodialysis is a form of treatment used to remove water and waste from the blood. During kidney failure, dialysis removes wastes such as...
FibroGen to Report Second Quarter 2022 Financial Results
25. Juli 2022 07:00 ET
|
FibroGen, Inc.
SAN FRANCISCO, July 25, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its second quarter 2022 financial results on Monday, August 8 after the market close. FibroGen will also...
Algernon Pharmaceuticals Provides Update on its Planned Phase 1 Repirinast Chronic Kidney Disease Study
11. Juli 2022 07:00 ET
|
Algernon Pharmaceuticals
VANCOUVER, British Columbia, July 11, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a clinical stage Canadian...